US Patent Issued to Handa Therapeutics on Nov. 25 for "Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses" (Minnesota Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,625, issued on Nov. 25, was assigned to Handa Therapeutics LLC (San Jose, Calif.).

"Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses" was invented by Christian F. Wertz (Saint Louis Park, Minn.) and Tzehaw Chen (Corcoran, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor dasatinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer, or in methods of delivering dasatinib to patients without regard to whether the patient is concurrently admini...